Advancing Menopause Care and Mid-Life Women’s Health Act
- Sponsor
- Rep. Clarke, Yvette D. [D-NY-9]
- Committees
- Energy and Commerce Committee (primary)
- Last action
- Jun 2, 2026
Bottom line
The bill aims to comprehensively address the current gaps in menopause care, research, and education to significantly improve health outcomes and quality of life for mid-life women across the United States.
What it actually does
This bill significantly expands federal research, public health promotion, awareness, and training initiatives related to menopause and mid-life women's health. It directs the National Institutes of Health (NIH) and the Department of Health and Human Services (HHS) to coordinate and expand research into menopausal symptoms and related chronic conditions, establish public health promotion activities, create a national awareness program, fund training for health professionals, and designate Centers of Excellence in menopause care. The bill authorizes specific appropriations for these activities for fiscal years 2027 through 2031.
Proponents argue
Proponents argue that the bill addresses a long-neglected area of women's health, which affects a significant portion of the population, by investing in critical research, improving public awareness, and enhancing the training of healthcare providers. They contend that this comprehensive approach will lead to better diagnostic tools, more effective treatments, reduced health disparities, and ultimately, a higher quality of life for women experiencing menopause and its associated conditions.
Opponents contend
Opponents may raise concerns about the overall increase in federal spending and the creation of new programs, particularly those with 'such sums as may be necessary' authorizations, which lack specific caps. They might argue for prioritizing existing health initiatives or question the efficiency of establishing new centers and grant programs rather than integrating these efforts into current structures, potentially leading to bureaucratic bloat or duplication of efforts.
The bill is relatively concise and clearly structured, making it accessible for an informed reader to understand its core provisions within a reasonable timeframe.
Section 2(a)
NIH Research Expansion on Menopause and Mid-Life Women's Health
This provision directs the Director of NIH, through the Office of Research on Women's Health, to coordinate and expand research activities across all NIH institutes. The research will focus on the impact of perimenopause, menopausal transition, and postmenopausal periods on women's physical, mental, and cognitive health, prevention of adverse outcomes, health disparities, and the development of integrated care approaches. It also authorizes grants for biomedical and public health research into new treatments and diagnostic services.
Supporters argue
Supporters argue that expanding NIH research is crucial to closing significant knowledge gaps in menopause and mid-life women's health, leading to evidence-based improvements in care and addressing long-standing underinvestment in this area.
Critics contend
Critics might argue that while research is valuable, the specific allocation of resources might not be optimal, or that existing NIH structures could absorb these research priorities without needing new, dedicated coordination mandates.
Tradeoffs
The provision balances the need for dedicated research with the challenge of coordinating across multiple existing NIH entities to avoid fragmentation and ensure efficient use of resources.
Section 2(b)
Public Health Research and Data Reporting
This section mandates the Secretary of HHS to expand public health research on the severity and duration of menopausal symptoms and related chronic conditions, including mental and behavioral health. It requires the establishment of a public dashboard for reporting data on menopausal symptoms and mid-life health outcomes, and directs occupational health research into workplace stressors related to severe menopausal symptoms.
Section 3
Public Health Promotion and Prevention Activities
This section directs the Secretary of HHS to expand public health promotion and prevention activities related to menopausal symptoms and chronic conditions. It authorizes grants to eligible entities for improving early detection, diagnosis, and treatment, and for supporting care coordination. Additionally, it mandates the development of recommendations and best practices for increasing access to mental and behavioral health care, substance use disorder services, and for reducing health disparities in menopause management.
Section 4
National Public Health Awareness, Education, and Outreach Program
This section establishes a national awareness, education, and outreach program on menopausal symptoms and mid-life women's health. The program is directed at patients, healthcare providers, first responders, and other stakeholders, aiming to disseminate educational materials, identify risk factors, and address barriers to care. It also requires the Secretary to develop and maintain an online resource with accessible educational materials.
Section 5
Training Programs to Improve Care and Treatment of Menopausal Symptoms
This provision authorizes the Secretary of HHS to award grants to eligible entities, such as medical schools, nursing schools, and hospitals, to develop or expand training programs. These programs include accredited residency programs, fellowships, and other clinical training for various health professionals (physicians, nurses, pharmacists, etc.) to improve their ability to care for, treat, and manage perimenopause, menopausal symptoms, and related chronic conditions.
Section 6
Centers of Excellence in Menopause Care and Mid-Life Women's Health
This section directs the Secretary of HHS to designate and award grants to eligible entities as Centers of Excellence in Menopause and Mid-Life Women's Health. These centers will focus on improving professional training resources for healthcare providers, developing and distributing evidence-based resources for providers, patients, and public health departments, and promoting advancements in treatment and prevention. The Secretary is directed to consider geographic distribution and prioritize entities serving health professional shortage areas or medically underserved populations.
Defines eligible entities for NIH research grants to include various accredited health professions schools (medicine, osteopathic, dental, nursing, pharmacy, physician assistant), teaching hospitals, certified behavioral health clinics, and specifically mentions Historically Black Colleges or Universities (HBCUs) and other minority-serving institutions by referencing sections of the Higher Education Act of 1965.
Section 2(a)(3)
Why it matters:Referencing existing definitions from other acts is standard legislative practice to avoid redundancy and ensure consistency with federal education policy. However, the specific inclusion of HBCUs and minority-serving institutions is a substantive policy choice that could be overlooked.
Case for: Supporters would argue that explicitly including HBCUs and minority-serving institutions ensures that research and training efforts are inclusive and directly address health disparities often found in the communities served by these institutions, fostering a more diverse research and healthcare workforce.
Case against: No specific opposition is typically raised against this type of inclusive language, as it aligns with broader federal goals of promoting diversity and equity in research and education.
Estimated impact: Ensures a broader and more equitable distribution of research grants, potentially leading to research that is more relevant to diverse populations and strengthens institutions serving minority communities.
Authorizes 'such sums as may be necessary' for fiscal years 2027 through 2031 for the Centers of Excellence in Menopause Care and Mid-Life Women's Health and for the Reporting Requirement.
Section 6(g) and Section 7(c)
Why it matters:This phrasing is standard for authorizing appropriations when the exact cost is difficult to project or when Congress intends to provide flexibility for future appropriations. However, it can obscure the potential financial commitment.
Case for: Proponents would argue that this flexibility is necessary for programs like Centers of Excellence, allowing funding levels to adapt to evolving needs and successful program expansion without requiring new legislation. For reporting, it ensures the necessary administrative functions are funded.
Case against: Critics often argue that 'such sums as may be necessary' provisions represent an open-ended commitment of taxpayer funds without clear budgetary limits, making it difficult to assess the true cost of the legislation.
Estimated impact: Potentially significant, as it allows for substantial future appropriations without a specified cap, depending on subsequent congressional action.